Evidence map›Paper›PMID 40087852›Full record

ArticleMicrobial biotechnology2025

Engineering Xylose Isomerase and Reductase Pathways in Yarrowia lipolytica for Efficient Lipid Production.

Isabel De La Torre, Miguel G Acedos, Juan J Cestero, Jorge Barriuso, José L García

Abstract read
In one paragraph

Article in Microbial biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Isabel De La TorreDepartment of Biotechnology, Centro de Investigaciones Biológicas Margarita Salas. Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.ORCID https://orcid.org/0000-0002-0460-8027
Miguel G AcedosDepartment of Biotechnology, Centro de Investigaciones Biológicas Margarita Salas. Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.ORCID https://orcid.org/0000-0003-4229-5698
Juan J CesteroDepartment of Biotechnology, Centro de Investigaciones Biológicas Margarita Salas. Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.
Jorge BarriusoDepartment of Biotechnology, Centro de Investigaciones Biológicas Margarita Salas. Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.ORCID https://orcid.org/0000-0003-0916-6560
José L GarcíaDepartment of Biotechnology, Centro de Investigaciones Biológicas Margarita Salas. Consejo Superior de Investigaciones Científicas (CSIC), Madrid, Spain.ORCID https://orcid.org/0000-0002-9238-2485

Funding

European Commission 101037031 (FRONTSH1P project)
6 · The paper itself

Abstract

Xylose is a common monosaccharide in lignocellulosic residues that Yarrowia lipolytica cannot naturally metabolise for lipid production and therefore, heterologous xylose metabolic pathways must be engineered in this yeast to facilitate its consumption. We have compared the metabolic efficiency of two xylose metabolic pathways by developing three recombinant Y. lipolytica strains: one harbouring a xylose reductase pathway, one with a xylose isomerase pathway, and one combining both pathways, and the strains were tested for xylose consumption and lipid production at different scales. The recombinant strain with the reductase pathway that was directly isolated in selective xylose medium showed the highest lipid yield, producing up to 12.8 g/L of lipids, or 43% of the biomass dry weight, without requiring any other xylose consumption adaptive evolution process. This strain achieved a lipid yield of 0.13 g lipids/g xylose, one of the highest yields in yeast reported so far using xylose as the sole carbon and energy source. Although the strain harbouring the isomerase pathway performed better under oxygen-limiting conditions and led to higher lipid intracellular accumulation, it showed a lower xylose uptake and biomass production, rendering a lower yield under non-limiting oxygen conditions. Unexpectedly, the combination of both pathways in the same strain was less effective than the use of the reductase pathway alone.

Indexed as

Aldehyde ReductaseAldose-Ketose IsomerasesLipidsMetabolic EngineeringMetabolic Networks and PathwaysYarrowiaBiomassXyloseAldehyde ReductaseAldose-Ketose IsomerasesLipidsXylosexylose isomeraselignocelluloselipidsxyloseYarrowia lipolytica

Identifiers

PMID40087852
PMCPMC11909007

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.